Tarsons Products Limited (TARSONS.BO)
INR 410.3
(-0.21%)
INR 410.3
(-0.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.59 Billion INR | 129.77% |
| 2022 | 1.56 Billion INR | 187.48% |
| 2021 | 543.96 Million INR | 5.39% |
| 2020 | 516.12 Million INR | 0.93% |
| 2019 | 511.37 Million INR | -33.32% |
| 2018 | 766.85 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -6.12 Billion INR | -270.56% |
| 2023 FY | 3.59 Billion INR | 129.77% |
| 2023 Q4 | 3.59 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.57 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 1.56 Billion INR | 187.48% |
| 2022 Q4 | 1.56 Billion INR | 0.0% |
| 2022 Q2 | 967.74 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | 958.12 Million INR | 85.64% |
| 2021 Q3 | - INR | 0.0% |
| 2021 FY | 543.96 Million INR | 5.39% |
| 2021 Q4 | 543.96 Million INR | 0.0% |
| 2020 Q1 | - INR | 0.0% |
| 2020 FY | 516.12 Million INR | 0.93% |
| 2020 Q4 | 516.12 Million INR | 0.0% |
| 2019 FY | 511.37 Million INR | -33.32% |
| 2018 FY | 766.85 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Poly Medicure Limited | 3.85 Billion INR | 6.819% |